000627 Hubei Biocause Pharmaceutical
- 3.41
- +0.31+10.00%
Hubei Biocause Pharmaceutical News
Tianmao Group (000627) 2020 Quarterly Report Review: Guohua Life Insurance Financial Asset Conversion Proceeds Drive Group Net Profit to Buck the Trend
Tianmao Group (000627) 2019 Report Review: Divestment of Non-Life Insurance Business Boosts Net Profit Guohua Life's Structure Optimization
Tianmao Group (000627): Guohua Life Insurance plans to list as a whole with both scarcity and uncertainty
Tianmao Group (000627): premium to maintain high growth, fixed increase approved to release vitality
Tianmao Group (000627) three-quarter report comments: business structure adjustment continues to increase and enhance financial strength
Tianmao Group (000627): judge the hour and size up the situation and realize outstanding results in the first half of the year.
Tianmao Group (000627): outstanding performance of insurance for successful transformation
Tianmao Group (000627) In-depth Research: Actively Laying Out Financial Holdings Is Optimistic About the Growth Potential of Company Transformation
[Shen Wan Hongyuan] Tianmao Group: actively layout financial control, optimistic about the growth potential brought about by the company's transformation.
In-depth study of Tianmao Group (000627): the embryonic form of comprehensive layout of insurance financial control
【华泰证券】天茂集团:借翼寿险扶摇上,待纳财险织金控
【安信证券】天茂集团:全面布局保险,金控雏形初显
天茂集团(000627)季报点评：借翼寿险扶摇上 待纳财险织金控
天茂集团(000627)深度报告：业绩绽放闪耀光芒 产寿合璧转型金控
深度*公司*天茂集团(000627)点评：一季度预计扭亏为盈 国华人寿贡献凸显
天茂集团(000627)点评：保险初绽放 深化调整造金控
【华泰证券】天茂集团:保险初绽放,深化调整造金控
【中银国际证券】天茂集团:产寿险兼备华丽转型,国华、天平叶落归根
深度*公司*天茂集团(000627)：产寿险兼备华丽转型 国华、天平叶落归根
天茂集团(000627)点评：加码保险 提升盈利能力
Analysis
Price Target
No Data
No Data